NEW YORK (GenomeWeb) – BioGx announced today that UK-based firm Launch Diagnostics will distribute assay products from BioGx's European-based subsidiary in the UK and Ireland.

As part of the multi-year partnership, Launch Diagnostics will collaborate with the Netherlands subsidiary of Birmingham, Alabama-based BioGx to distribute its CE-IVD-marked product line for infectious diseases, in addition to laboratory-use-only products, Template Positive Controls, and ValidPaks to expedite customer validation studies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.